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M

yt1 was originally identiﬁed as an inhibitory
kinase for Cdc2 (Cdk1), the master engine of
mitosis, and has been thought to function, together
with Wee1, as a negative regulator of mitotic entry. In this
study, we report an unexpected ﬁnding that Myt1 is essential for Golgi and endoplasmic reticulum (ER) assembly
during telophase in mammalian cells. Our analyses reveal

that both cyclin B1 and cyclin B2 serve as targets of Myt1
for proper Golgi and ER assembly to occur. Thus, our results show that Myt1-mediated suppression of Cdc2 activity is not indispensable for the regulation of a broad range
of mitotic events but is speciﬁcally required for the control
of intracellular membrane dynamics during mitosis.

Introduction
Activation of Cdc2 and its translocation to the nucleus are the
crucial events controlling entry into mitosis (Nurse, 1990; Hunt,
1991; Pines, 1999; Takizawa and Morgan, 2000). In multicellular eukaryotes, the kinase activity of Cdc2 is generally considered to be regulated by inhibitory phosphorylation on Thr14
and Tyr15, which are catalyzed by Wee1 and Myt1 (Lew and
Kornbluth, 1996; Nigg, 2001). Wee1, which was identified originally in a Schizosaccharomyces pombe mutant with a small cell
or wee phenotype, is a tyrosine-specific protein kinase conserved in all eukaryotes. Human Wee1 is nuclear and phosphorylates Cdc2 exclusively on Tyr15 (Parker and Piwnica-Worms,
1992; Heald et al., 1993; McGowan and Russell, 1993; Parker
et al., 1995). Myt1, a membrane-associated kinase, is present in
metazoans and phosphorylates Cdc2 on both Thr14 and Tyr15
residues (Kornbluth et al., 1994; Mueller et al., 1995; Booher
et al., 1997; Liu et al., 1997, 1999; Wells et al., 1999; Okumura
et al., 2002). Thus, both Myt1 and Wee1 have been thought to
function as negative regulators of mitotic entry.
In several known species, Myt1 but not Wee1 is present in
immature oocytes and mediates prophase I arrest by inhibiting
Cdc2 (Nakajo et al., 2000; Okumura et al., 2002). In Xenopus
laevis oocytes, injection of neutralizing anti-Myt1 antibodies
induces germinal vesicle breakdown, presumably through the
activation of Cdc2 (Nakajo et al., 2000). In Caenorhabditis
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elegans hermaphrodites, Myt1 depletion using RNAi has been
shown to cause precocious maturation of oocytes (Burrows
et al., 2006). Mutations in Myt1 in C. elegans also implicate its
role in the regulation of male meiosis (Lamitina and L’Hernault,
2002). Furthermore, Drosophila melanogaster Myt1 has been
shown to be important for the regulation of both mitotic and
meiotic cell cycles during gametogenesis (Jin et al., 2005).
More proliferating cells were observed in null myt1 mutant testes and ovaries than in controls, and male myt1 mutants show
complete sterility. In addition, the loss of Myt1 causes elevated
nondisjunction in homologous chromosome segregation during
female meiosis I (Jin et al., 2005). Thus, Myt1 has a pivotal role
in gametogenesis in various species. However, it is not known
whether Myt1 functions to regulate mitotic entry during somatic
cell cycles in vertebrates.
In this study, we examine the role of Myt1 in mammalian
somatic cell cycles. Our results show that although the inhibition
of Wee1 expression by siRNA markedly accelerates mitotic entry,
inhibition of Myt1 expression does not change the timing of mitotic entry. Interestingly, our analysis demonstrates that Myt1 depletion induces severe defects in Golgi and ER assembly during
mitotic exit. Thus, Myt1 is essential for Golgi and ER assembly at
the end of mitosis. Furthermore, cyclin B1 and B2 knockdown
experiments demonstrate that Myt1 functions to facilitate Golgi
and ER assembly through its ability to suppress both cyclin B1–
and cyclin B2–Cdc2 activities. Thus, our findings have identified
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Myt1 as an essential regulator of intracellular membrane dynamics during mitosis in mammalian somatic cell cycles.

Results
The effects of Myt1 and Wee1 siRNAs on
the timing of mitotic entry in HeLa cells

To determine whether human Myt1 levels vary throughout the somatic cell cycle, we examined Myt1 protein levels in synchronized HeLa cells. Myt1 levels peaked at M phase, at 9–11 h after
release from a thymidine block, and markedly decreased after M
phase (Fig. 1 A, top left). In contrast to cyclin B1, whose protein
levels peaked at 9 h and dropped rapidly, Myt1 protein levels remained high at 10–11 h, indicating that Myt1 is present at relatively high levels during M phase even after the metaphase-anaphase

transition. As previously reported, the mobility of Myt1 is reduced
on SDS gels as a result of phosphorylation during M phase (Mueller
et al., 1995; Booher et al., 1997; Liu et al., 1997, 1999; Wells et al.,
1999; Okumura et al., 2002). To exclude the possibility that the
antibody used might recognize slower migrating forms of Myt1
more strongly, we examined Myt1 protein levels after treating cell
extracts with  phosphatase. The result also shows that Myt1 protein levels increase during M phase (Fig. 1 A, top right). Moreover,
the decrease of Myt1 observed after M phase was markedly suppressed by treatment with MG132, a proteasome inhibitor (Fig. 1 A,
bottom right), indicating that Myt1 degradation directly or indirectly requires the ubiquitin-proteasome system at the end of M
phase or during G1 phase.
To examine the role of Myt1 in mitotic entry in somatic
cell cycles, siRNA was used to reduce Myt1 levels in synchronized

Downloaded from jcb.rupress.org on November 8, 2011
Figure 1. The effect of Myt1 and Wee1 siRNAs on the timing of mitotic entry in HeLa cells. (A) Extracts were prepared from HeLa cells synchronized by
a double-thymidine block and analyzed by SDS-PAGE followed by immunoblotting with anti-Myt1, anti–cyclin B1, and anti–␣-tubulin antibodies (top and
bottom left). MG132 was added to synchronized cells 8 h after release (bottom right). Extracts from synchronized cells were treated with or without 
protein phosphatase and were subjected to immunoblotting with anti-Myt1 and anti–␣-tubulin antibodies (top right). (B) HeLa cells were transfected with
Myt1 or Wee1 siRNA in the interval between the two thymidine blocks (top; experimental protocol). Cell extracts were analyzed by SDS-PAGE followed
by immunoblotting with anti-Myt1, anti-Wee1, and anti–␣-tubulin antibodies (bottom left). The cells were examined for the percentage of mitotic cells using
antiphosphohistone H3 antibody (bottom right). More than 300 cells were examined, and the percentages are shown as mitotic index.
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HeLa cells. HeLa cells were transfected with Myt1 siRNA during the interval between the two thymidine blocks (Fig. 1 B,
top). The percentage of mitotic cells was determined using a
phosphohistone H3 antibody that specifically detects mitotic
cells. The effect of Wee1 siRNA on the timing of mitotic entry
was also examined. In untreated control cells, the percentage of
the mitotic cells peaked at 10 h after release from the G1/S
block (Fig. 1 B). The Myt1 siRNA-treated cells showed almost the same time course of mitotic entry as the control cells,
whereas the Wee1 siRNA-treated cells entered mitosis much
earlier than the control and Myt1 siRNA-treated cells (Fig. 1 B).
Essentially the same results were obtained in another series of
experiments in which MPM2-positive cells or condensed chromosomes were used as the mitotic indices (unpublished data).
These results suggest that Myt1, unlike Wee1, may be less important for regulating mitotic entry timing in HeLa cells.

In Myt1 siRNA-treated cells, a mitotic spindle was formed normally, and interphase microtubules emanated from centrosomes
normally and extended toward the cell periphery, although they
appeared to be slightly less dense (Fig. 2 A). In these cells, the
number and size of centrosomes were also apparently normal, and
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Myt1 is necessary for Golgi reassembly
during telophase

the actin cytoskeleton and lysosomes were indistinguishable from
those in control cells (Fig. 2 B). The Golgi apparatus, however,
displayed a dramatically transformed morphology in Myt1depleted cells. Immunofluorescence staining for Golgi matrix
proteins GM130 and p115 revealed markedly condensed nonribbon-like membranous structures near the nucleus, which
are clearly different from normal Golgi structures in control cells
(Fig. 3 A) and control siRNA-treated cells (not depicted). Immunofluorescence staining for other Golgi markers, including
v-SNARE GS15, t-SNARE Vti1a, and Golgin-245/p230, revealed
similar differences in the staining patterns between Myt1-depleted
cells and control cells (unpublished data). Furthermore, most ER
exit sites localized around such Golgi marker–positive condensed
structures (Fig. 3 C). Interestingly, ␥-adaptin, which localizes to
the TGN in control cells, rarely associated with these abnormal
membranous structures in Myt1-depleted cells but rather was dispersed throughout the cytoplasm (Fig. 3 B). In Myt1-depleted
cells, the other TGN markers, Golgin97 and TGN38, were not
dispersed but associated with the condensed membranous structures like other cis- and medial-Golgi markers (Fig. 3 B and not
depicted). As ␥-adaptin is a clathrin adaptor and functions to facilitate transport from the TGN to both endosomes and the plasma
membrane, Myt1-depleted cells may be deficient in these transporting abilities. A portion of Myt1-depleted cells displayed large

Figure 2. Effect of Myt1 depletion on cytoskeleton and subcellular organelles. HeLa
cells were transfected with Myt1 siRNA and
incubated for 48 h. (A) M-phase (top) and interphase (bottom) cells were stained with anti–
␣-tubulin antibody (green) together with Hoechst
(blue). (B) Cells were stained with anti–␥-tubulin
antibody for centrosomes (left), ﬂuorescent
phalloidin for actin cytoskeleton (middle), and
anti-LAMP1 antibody for lysosomes (right; red)
together with Hoechst (blue). Bars, 10 μm.
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Figure 3. Depletion of Myt1 induces dramatic
changes in the Golgi apparatus and ER exit sites.
HeLa cells were transfected with Myt1 siRNA and
incubated for 48 h. (A) The cells were stained with
anti-GM130 and anti-p115 antibodies (red) together
with Hoechst (blue). High resolution images (GM130)
were obtained by deconvolution (bottom). (B) The
cells were stained with anti–␥-adaptin antibody (red)
together with anti–Golgin97 antibody (green) and
Hoechst (blue). (C) The cells were stained with antiSec31A antibody (red) for ER exit sites together with
anti-GM130 antibody (green) and Hoechst (blue).
Bars, 10 μm.

Downloaded from jcb.rupress.org on November 8, 2011

vacuoles (unpublished data), which may be the result of transport
defects. Moreover, we found that Myt1-depleted cells showed a
retarded proliferation rate and died within 10 d. Thus, Myt1 is
likely to be essential for Golgi structure and function.
Myt1 might function to maintain Golgi structure during
interphase, or, alternatively, Myt1 might be essential for Golgi
92
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reassembly during mitotic exit. The Golgi apparatus fragments
into thousands of vesicles and tubules during prometaphase
and rapidly reassembles during telophase in mammalian cells
(Shorter and Warren, 2002). To distinguish between these two
possibilities, we transfected synchronized HeLa cells with Myt1
siRNA as in Fig. 1 B and stained the cells with anti-GM130 antibody
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Figure 4. Myt1 is required for Golgi reassembly during telophase. (A) Synchronized HeLa cells were transfected with Myt1 siRNA as in Fig. 1 B, and cells
at 8 (G2), 11 (M), and 15 h (G1) after the release were stained with anti-GM130 antibody (red) and Hoechst (blue). (B) Representative electron microscopy images of Golgi in cells that were transfected with or without Myt1 siRNA and incubated for 48 h. (C) Immunolabeling electron microscopy images
of the Golgi area in HeLa cells transfected with or without Myt1 siRNA. For immunolabeling of Golgi marker proteins, monoclonal antibody to GM130
was used. (B and C) Arrows show cisternae or long tubules. White arrowheads show transport vesicles, and black arrowheads show short tubules and
vesicles. Bars: (A) 10 μm; (B and C) 0.2 μm.

as cells progressed through the cell cycle after release from the
G1/S block. In G2 phase, Myt1-depleted cells had normal ribbonlike Golgi structures (Fig. 4 A, 8 h) in spite of the complete loss
of Myt1 (Fig. 1 B). Also, the Golgi fragmentation occurred
normally during prometaphase in Myt1-depleted cells (Fig. 4 A,
11 h). However, in G1 phase after mitosis, the staining pattern
showed abnormal, markedly condensed, nonribbon-like membranous structures (Fig. 4 A, 15 h). Thus, Myt1 depletion induced
severe defects in Golgi reassembly. We confirmed that such a

phenotype persisted through G1 into S and G2 phases (unpublished data). We have also revealed that Golgi restoration after
brefeldin A washout in Myt1-depleted cells was normal and not
delayed compared with the restoration in control cells (unpublished data). These results have clearly shown that Myt1 is required for Golgi reassembly during telophase but not for the
maintenance of Golgi structure during interphase.
Electron microscopy was used to examine the morphology of the Golgi apparatus in Myt1-depleted cells. Although the
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Figure 5. Myt1 is required for ER meshwork formation. (A) HeLa cells were transfected with Myt1 siRNA and incubated for 48 h. The ER was visualized
with ER tracker red in living cells without ﬁxation. (B) The cells in A were classiﬁed into three types based on the ER morphology. The cells that have a
ﬁne ER meshwork consisting of typical tubular structures throughout the cytoplasm were classiﬁed into a ﬁne meshwork type (labeled as F). The cells that
have a coarse ER meshwork and thick, cisternae-like structures in the cell periphery were classiﬁed into a coarse meshwork type (labeled as C). The cells
that show intermediate phenotypes were classiﬁed into a ﬁne/coarse meshwork type (labeled as F/C). More than 40 cells were examined. The bars are
the mean of two independent experiments. (C) Synchronized HeLa cells were transfected with Myt1 siRNA as in Fig. 1 B, and ER was visualized with ER
tracker red in living cells at 8 (G2), 11 (M), and 15 h (G1) after the release. (D) The G2 and G1 cells in C are classiﬁed into three types based on the
ER morphology. More than 45 cells were examined in each experiment, and experiments were performed twice. (B and D) Error bars represent ±SD.
Bars, 10 μm.

normally stacked Golgi cisternae could be observed in more
than three fourths of control cells (Fig. 4 B, control), stacked
Golgi-like cisternae could be detected only in approximately
one third of Myt1 siRNA-treated cells. Moreover, the stacked
Golgi-like cisternae in Myt1-depleted cells were loosely stacked
94
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and abnormal in appearance (Fig. 4 B, Myt1 siRNA; right). Two
types of aberrant membranous structures were observed exclusively in Myt1-depleted cells (Fig. 4 B, Myt1 siRNA; left and
middle). These included structures composed of short tubules
and an abundance of vesicles (Fig. 4 B, Myt1 siRNA; left),

Published March 31, 2008

which were likely derived from mitotic Golgi fragments, and
condensed structures consisting of vesicles surrounded by abnormally bended stacks of long tubules (Fig. 4 B, Myt1 siRNA;
middle). Immunoelectron microscopy using an anti-GM130 antibody (Fig. 4 C) revealed that the abnormal membranous structures were derived from Golgi fragments and may correspond to
the condensed nonribbon-like membranous structures seen with
immunofluorescence staining (Fig. 3 A). Thus, the electron
microscopy data support the conclusion that Myt1 functions to
facilitate Golgi reassembly during telophase.
Myt1 is necessary for ER meshwork
formation during telophase

Kinase activity of Myt1 is necessary for
Golgi and ER reassembly

To ensure that Myt1 siRNA specifically depletes cells of Myt1,
we performed add-back experiments in synchronized HeLa cells.
Expression of an siRNA-resistant form of Myt1 almost completely rescued the Golgi reassembly defect (Fig. 6 A, Myt1
siRNA + Myt1-WT; arrows). In contrast, expression of the
siRNA-resistant form of Myt1 that lacks kinase activity did
not rescue the phenotype (Fig. 6 A, Myt1 siRNA + Myt1-KD).
To semiquantify the Golgi defect, GM130-stained images were

Downloaded from jcb.rupress.org on November 8, 2011

Golgi is closely related to the ER (Lippincott-Schwartz et al.,
2000). The ER is a continuous membrane system enclosing
a single luminal space and comprises fine tubular networks
and cisternae throughout the cytoplasm (Voeltz et al., 2002;
Shibata et al., 2006). ER tracker labeling in live cells revealed
that a fine ER meshwork became disrupted in Myt1 siRNAtreated cells; the meshwork of tubular structures became coarse,
and thick, cisternae-like structures appeared in the cell periphery in Myt1-depleted cells (Fig. 5 A). To semiquantify this
phenotype, the cells were classified into three types based on
the ER morphology. The cells that had a fine ER meshwork
consisting of typical tubular structures throughout the cytoplasm were classified into a fine meshwork type (Fig. 5 B, bars
labeled F). The cells that had a coarse ER meshwork and thick,
cisternae-like structures in the cell periphery were classified
into a coarse meshwork type (Fig. 5 B, bars labeled with C).
The cells that show intermediate phenotypes were classified
into a fine/coarse meshwork type (Fig. 5 B, bars labeled with
F/C). The semiquantification data in Fig. 5 B clearly show that
Myt1 depletion induces disruption of a fine ER meshwork.
When synchronized HeLa cells were transfected with Myt1
siRNA as in Fig. 1 B, Myt1-depleted cells had a normal, fine
ER meshwork in G2 phase (Fig. 5, C and D; 8 h [G2]) in spite
of the complete loss of Myt1 (Fig. 1 B), and, during mitosis,
the ER morphology in Myt1-depleted cells was indistinguishable from that in control cells (Fig. 5 C, 11 h). However, in G1
phase after mitosis, ER tracker labeling showed an abnormal
coarse meshwork of ER (Fig. 5, C and D; 15 h [G1]). Thus,
Myt1 depletion induced severe defects in reassembly of a fine
ER meshwork. Therefore, Myt1 is required for reassembly
of a fine, interphase-type ER meshwork during mitotic exit
but not for biogenesis or maintenance of an ER meshwork
during interphase.

Figure 6. Kinase activity of Myt1 is necessary for Golgi reassembly.
(A) HeLa cells were transfected with or without Myt1-WT or Myt1-KD
(a kinase-inactive form of Myt1), which is resistant to Myt1 siRNA, together
with CFP as an indicator of Myt1-expressing cells before the ﬁrst thymidine block, and then Myt1 siRNA treatment was performed after the ﬁrst
thymidine block. 15 h after the release from G1/S block, cells were subjected to immunoblotting with anti-Myt1 antibody (top) or were ﬁxed and
stained with anti-GM130 antibody (red; bottom). Exogenous Myt1 levels
in Myt1-depleted cells were lower than endogenous Myt1 levels in control
cells (top). We conﬁrmed that this level of Myt1 expression did not inhibit
entry into mitosis (not depicted). Exogenous Myt1 was expressed only in
CFP-positive cells (blue; bottom), and the Golgi reassembly defect was
completely rescued by the expression of Myt1-WT (bottom left; arrows).
(B) The relative Golgi area in anti-GM130 images in the cells described
in A were measured (see Materials and methods). The percentage of cells
whose Golgi area was smaller than one SD from the mean Golgi area of
control cells was determined. More than 200 cells were examined in each
experiment, and experiments were performed twice. The results obtained
from each independent experiment are represented as distinct bars (gray
and black bars for each experiment). Bar, 10 μm.
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Figure 7. Kinase activity of Myt1 is necessary
for ER reassembly. (A) HeLa cells were transfected with or without Myt1-WT or Myt1-KD,
which is resistant to Myt1 siRNA, together with
CFP as an indicator of Myt1-expressing cells
before the ﬁrst thymidine block, and then Myt1
siRNA treatment was performed after the ﬁrst
thymidine block. ER was visualized with ER
tracker red in living cells 15 h after the release.
(B) CFP-positive cells in A were classiﬁed into
three types based on the ER morphology as
described in Fig. 5 B. More than 32 cells were
examined in each experiment, and experiments were performed twice or more. The bars
are the mean of more than two independent
experiments. Error bars represent ±SD. F, ﬁne
meshwork type; C, coarse meshwork type;
F/C, ﬁne/coarse meshwork type. Bar, 10 μm.

96

JCB • VOLUME 181 • NUMBER 1 • 2008

Myt1 functions to facilitate Golgi and
ER assembly through both cyclin B1
and cyclin B2

Cdc2 is the only known substrate of Myt1 (Booher et al., 1997).
Cdc2 is bound to mitotic B-type cyclins and is then activated
to form M phase–promoting factor (Nurse, 1990; Hunt, 1991).
There are three mammalian B-type cyclins: cyclin B1, B2, and
B3. Among these B-type cyclins, mammalian cyclin B3 is
thought to be a meiosis-specific cyclin because it is detected in
both the testis and ovary but not in any other tissues. The mRNA
and the protein of human cyclin B3 could not be detected in
HeLa cells (Nguyen et al., 2002). In contrast, cyclin B1 and cyclin B2 are ubiquitously present in somatic cells, and both protein levels peak at M phase (Pines, 1999). In our analysis in
synchronized HeLa cells, cyclin B1 was mostly degraded during
metaphase and anaphase (at ⵑ10 h after release in this series of
experiments) as previously reported (Clute and Pines, 1999), but
the protein appeared to be present at very low levels even in late
mitosis (at ⵑ11–12 h; Fig. 8 A). In the same series of experiments, cyclin B2 was also mostly degraded after metaphase,
but low levels, which were slightly higher than cyclin B1 levels,
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used to measure the Golgi area in Myt1-depleted and -restored
cells. 19% of control cells and 52% of Myt1-depleted cells had
a Golgi area smaller than one SD from the mean measured in
control cells (Fig. 6 B). Expression of Myt1 in Myt1-depleted
cells reduced the percentage of small, compact Golgi from 52 to
16% (Fig. 6 B), indicating an almost complete rescue of the
phenotype. Expression of kinase-inactive Myt1 was unable to
restore the integrity of the Golgi (43% of control; Fig. 6 B).
These results demonstrate that the kinase activity of Myt1 is
required for Golgi reassembly.
The Myt1 add-back experiments were also performed to
examine the ER morphology in synchronized HeLa cells. When
the siRNA-resistant form of Myt1 was expressed in Myt1
siRNA-treated cells, the ER reassembly defect, that is, the defect in reassembly of an interphase-type ER meshwork during
telophase, was mostly rescued, and a fine ER meshwork appeared (Fig. 7, A and B; Myt1 siRNA + Myt1-WT). In contrast,
expression of the siRNA-resistant form of Myt1 that lacks
kinase activity did not rescue the ER reassembly defect (Fig. 7,
A and B; Myt1 siRNA + Myt1-KD). Thus, the kinase activity
of Myt1 is also required for ER reassembly.

Published March 31, 2008
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Figure 8. Residual cyclin B–Cdc2 during mitotic exit. (A) Extracts from HeLa cells synchronized by a double-thymidine block were analyzed by SDSPAGE followed by immunoblotting with anti–cyclin B1, anti–cyclin B2, and anti–␣-tubulin antibodies. (B) HeLa cells were transfected with GFP–cyclin B1
or GFP–cyclin B2 together with DsRed–histone H1 and were monitored by time-lapse video microscopy. Time-lapse sequences taken every 5 min from
metaphase to mitotic exit are shown. These data are representative of >10 cells in separate experiments. Time is given in minutes. (C) Extracts from HeLa
cells synchronized by a double-thymidine block were analyzed by immunoprecipitation with antibody against cyclin B1 followed by immunoblotting with
antibodies against Cdc2 and cyclin B1. The image with short exposure time on the same gel is shown in the right panel. (D) HeLa cells were transfected
with or without Myt1 siRNA in the interval between the two thymidine blocks. The cell extracts were subjected to immunoblotting with antiphospho-Ser25GM130, anti-GM130, anti-Myt1, and anti–cyclin B1 antibodies. (E) Myc-tagged Myt1 was coexpressed with GFP–cyclin B2, and the cells were analyzed
by immunoprecipitation with antibody against Myc followed by immunoblotting with antibodies against GFP and Myc (top). HeLa cells that were synchronized by a double-thymidine block were treated with 125 ng/ml nocodazole 8.5 h after the release and were harvested up to 12 h to gather mitotically
arrested cells. The cells were analyzed by immunoprecipitation with antibody against cyclin B2 followed by immunoblotting with antibodies against cyclin
B2 and Myt1 (bottom). Bar, 10 μm.

remained in late M phase and even early G1 phase (Fig. 8 A).
To examine the levels of cyclin B1 and cyclin B2 in more detail, we
performed time-lapse video microscopy experiments. Synchronized HeLa cells were transfected with GFP–cyclin B1 or

–cyclin B2 together with DsRed–histone H1 and were monitored
during mitosis by time-lapse video microscopy. We confirmed
that the protein levels of GFP–cyclin B1 and GFP–cyclin B2
were comparable with, or, at most, were less than three times the
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levels of endogenous cyclin B1 and cyclin B2, respectively (unpublished data). Although GFP–cyclin B1 began to be degraded
at metaphase as previously reported (Clute and Pines, 1999),
GFP–cyclin B2 began to be degraded after metaphase (Fig. 8 B).
Most importantly, low but significant levels of both GFP–cyclin
B1 and GFP–cyclin B2 persisted even in anaphase and telophase
(Fig. 8 B). These data suggest that when Golgi and ER reassembly occur during telophase, low levels of B-type cyclins are
present as partners of Cdc2. As Cdc2 activity plays a role in
promoting Golgi disassembly and ER network reorganization to
the M-phase type during early mitosis, it is likely that the kinase
activity of Cdc2 must be suppressed during telophase; otherwise,
the kinase activity would prevent Golgi and ER reassembly.
We hypothesized that Myt1 inhibits Cdc2 activity during telophase.
If our hypothesis is correct, Cdc2 would be phosphorylated
on Thr14/Tyr15 during mitotic exit. To address this, we examined
the phosphorylation state of Cdc2 in the cyclin B1–Cdc2 complex
98
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in synchronized HeLa cells by immunoblotting. The decreased
gel mobility of Cdc2 is known to be caused by the phosphorylation of Thr14 and Tyr15 (Norbury et al., 1991; Solomon et al.,
1992). The obtained results have clearly demonstrated that
Cdc2, which was coprecipitated with cyclin B1, was mostly
phosphorylated on both Thr14 and Tyr15 in late G2 at 9 h, and
the major population of Cdc2 was the dephosphorylated form at
the onset of mitosis at 10 h (Fig. 8 C). Most importantly, just
before cyclin B1 disappeared in late mitosis, the amount of
phosphorylated Cdc2 became similar to or greater than that of
unphosphorylated Cdc2 (at 13 h; Fig. 8 C). In seven independent experiments, we obtained similar results. Consistent with
our results, Jin et al. (1998) previously showed that when a stabilized form of cyclin B1 was expressed in synchronized HeLa
cells, Cdc2 phosphorylation was increased during mitotic exit,
and the cells were capable of exiting mitosis. Thus, our results
and the results of Jin et al. (1998) strongly suggest that there is
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Figure 9. Golgi fragmentation/reassembly and morphological changes of ER occur almost normally during mitosis in cyclin B1/cyclin B2 double siRNA–
treated cells. HeLa cells were transfected with cyclin B1 and cyclin B2 siRNAs in the interval between the two thymidine blocks. (A) The cells at 8 (G2), 11
(metaphase and anaphase), and 18 h (G1) after the release were stained with anti-GM130 antibody (red) and Hoechst (blue). (B) ER was visualized with
ER tracker red in living cells at 8 (G2), 11–12 (metaphase and anaphase), and 18 h (G1) after the release. Bars, 10 μm.
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Discussion
In this study, we have examined the role of Myt1 in mammalian
somatic cell cycles. We first show that inhibition of Myt1 expression by siRNA in HeLa cells does not change the timing of
mitotic entry but rather induces severe defects in the morphology
of the Golgi and ER, resulting in abnormally condensed Golgi
structures and disrupted ER meshwork. Our results then show
that the Golgi and ER morphology defects are observed after the
cells pass through mitosis. These results demonstrate that Myt1
is required for Golgi and ER reassembly during mitotic exit, not
for the biogenesis or maintenance of Golgi and ER structures
during interphase. Moreover, our finding that add back of wildtype but not kinase-inactive Myt1 rescues the Golgi and ER reassembly defects seen in Myt1-depleted cells demonstrates that the
kinase activity of Myt1 is required for Golgi and ER reassembly.
Myt1 is known to bind to cyclin B1, and here it is shown to bind
to cyclin B2 as well. Remarkably, inhibition of both cyclin B1
and cyclin B2 expression by siRNAs markedly rescues the Myt1
siRNA-induced Golgi and ER reassembly defects. These results
strongly suggest that Myt1 functions to facilitate Golgi and ER
reassembly during mitotic exit by suppressing both cyclin B1–
and cyclin B2–Cdc2 activities. We have also found that Wee1
siRNA-treated HeLa cells enter mitosis much earlier than the
control and Myt1 siRNA-treated cells. However, it has previously been reported that expression of Cdc2AF (a mutant form
of Cdc2 in which Thr14 and Tyr15 are changed to Ala and Phe)
in HeLa cells to levels that markedly elevate histone H1 activity
does not advance the timing of nuclear envelope breakdown or
chromatin condensation (Blasina et al., 1997; Jin et al., 1998).
This result indicates that the activation of Cdc2 is not sufficient
to induce nuclear envelope breakdown or chromatin condensation. Therefore, we may speculate that Wee1 has an additional
role. For example, Wee1 might inhibit the nuclear accumulation
of cyclin B1–Cdc2, or Wee1 might inhibit cyclin B–Cdc2 by its
direct interaction. Future studies are needed to analyze the phenotypes of Wee1 knockdown cells in more detail.
Mitotic Golgi fragmentation and reassembly are crucial
events in mammalian cells. Golgi fragmentation is thought to
facilitate the equal partitioning of Golgi membranes between
the two daughter cells during cell division (Shorter and Warren,
2002) and has recently been reported to be important for mitotic
progression (Sutterlin et al., 2002; Hidalgo Carcedo et al.,
2004). Golgi reassembly, then, is an essential process for establishing a functional Golgi apparatus (Shorter and Warren, 2002).
Mitotic Golgi fragmentation in mammalian cells is dependent
on Cdc2 (Lowe et al., 1998). Golgi proteins such as GM130,
GRASP65, p47, and Rab1, which play a crucial role in heterotypic or homotypic membrane fusion or stacking of Golgi cisternae, are substrates of Cdc2 (Shorter and Warren, 2002). Cdc2mediated phosphorylation of these Golgi proteins is expected
to promote mitotic Golgi disassembly through the cessation
of vesicle transport and unstacking of existing cisternae. Thus,
during telophase, these phosphoproteins must be dephosphorylated for proper Golgi reassembly to occur. Therefore, the
active Cdc2 would need to be inactivated during telophase to
ensure Golgi reassembly. Our results with cyclin B1 and cyclin
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an increase in phospho-Thr14/Tyr15 of Cdc2 during mitotic
exit. Furthermore, we have revealed that the phosphorylation of
GM130 on Ser25, which is one of the targets of Cdc2 on the
Golgi (Lowe et al., 1998, 2000), persisted for a prolonged period during mitotic exit in synchronized Myt1-depleted HeLa
cells compared with control cells (Fig. 8 D). This result suggests that residual cyclin B–Cdc2 should be suppressed by Myt1
during mitotic exit.
It has previously been shown that Myt1 associates with
cyclin B1 (Liu et al., 1999). Thus, we tested whether Myt1 associates with cyclin B2 as well. When Myc-tagged Myt1 was
coexpressed with GFP–cyclin B2, Myc-Myt1 coprecipitated
with GFP–cyclin B2 (Fig. 8 E, top). Moreover, Myc-Myt1 colocalized with GFP–cyclin B2 (unpublished data). In addition,
endogenous Myt1 coprecipitated with endogenous cyclin B2 in
mitotic HeLa cells (Fig. 8 E, bottom). These results suggest that
both cyclin B1–Cdc2 and cyclin B2–Cdc2 could be targets of
Myt1 and that both activities might be suppressed by Myt1 during Golgi and ER reassembly at the end of mitosis. To test this,
we inhibited cyclin B1 and cyclin B2 expression by siRNA in
Myt1 siRNA-treated and untreated asynchronous HeLa cells
(see Fig. 10 A). Although the single siRNA treatment for each
target almost completely depleted the cells of the target, it was
difficult to find the conditions in which the triple siRNA treatment for cyclin B1, cyclin B2, and Myt1 could almost completely abolish the expression of three proteins. Thus, under the
conditions we used here, cyclin B1 expression was almost completely inhibited, but low levels of Myt1 and cyclin B2 expression remained (see Fig. 10 A). However, this level of Myt1
down-regulation (ⵑ90% depletion) induced the Golgi and ER
morphology defects (see Fig. 10, B and C), which were indistinguishable from those resulting from the almost complete loss
of Myt1, as shown in Figs. 3 A and 5 A. Cyclin B1 and/or cyclin
B2 down-regulation in combination or alone in Myt1 siRNAuntreated cells had little effect on the Golgi and ER morphology
both in interphase and in M phase; that is, even in cyclin
B1/cyclin B2 double siRNA–treated synchronized HeLa cells,
the Golgi fragmentation and reassembly during mitosis occurred
almost normally (Fig. 9 A), and ER meshwork changes during
mitosis also occurred almost normally (Fig. 9 B), although a
significant proportion (ⵑ30%) of cyclin B1/cyclin B2 double
siRNA–treated cells displayed micronuclei or multinuclei (Fig.
10 B and not depicted). Either cyclin B1 or cyclin B2 downregulation in Myt1 siRNA-treated cells partially rescued the
Golgi and ER morphology defects seen in Myt1-depleted cells.
Remarkably, both cyclin B1 and cyclin B2 down-regulation
almost completely rescued the defects (Fig. 10, B–D); in the
Myt1/cyclin B1/cyclin B2 triple siRNA–treated cells, the Golgi
apparatus resumed a normal ribbonlike appearance (Fig. 10 B),
and ER resumed a fine interphase-type meshwork (Fig. 10,
C and D). The significant proportion of Myt1/cyclin B1/B2 triple
siRNA–treated cells also displayed micronuclei or multinuclei.
Even in these cells, the normal ribbonlike appearance of the
Golgi apparatus and fine ER meshwork was almost completely
restored (Fig. 10, B–D). These results strongly suggest that Myt1
facilitates Golgi and ER reassembly by suppressing both cyclin
B1– and cyclin B2–Cdc2 activities.

99

Published March 31, 2008

Downloaded from jcb.rupress.org on November 8, 2011
Figure 10. Myt1 functions to facilitate Golgi and ER assembly through both cyclin B1 and cyclin B2. HeLa cells were transfected with Myt1, cyclin B1, or
cyclin B2 siRNA (alone or in combination) and incubated for 48 h. (A) The cells were subjected to immunoblotting with antibodies against Myt1, cyclin B1,
cyclin B2, and ␣-tubulin. (B) The cells were ﬁxed and stained with anti-GM130 antibody (red) and Hoechst (blue). (C) ER was visualized with ER tracker red in
living HeLa cells. (D) The cells in C were classiﬁed into three types based on the ER morphology as described in Fig. 5 B. More than 45 cells were examined
in each experiment, and experiments were performed more than twice. The cells were subjected to immunoblotting with antibodies against Myt1, cyclin B1,
cyclin B2, and ␣-tubulin. Error bars represent ±SD. F, ﬁne meshwork type; C, coarse meshwork type; F/C, ﬁne/coarse meshwork type. Bars, 10 μm.

B2 down-regulation experiments strongly suggest that Myt1
facilitates Golgi reassembly through inhibition of both cyclin
B1– and cyclin B2–Cdc2 activities during telophase.
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ER is a continuous membrane system enclosing a single
luminal space and comprises tubular networks and cisternae
throughout the cytoplasm (Voeltz et al., 2002; Shibata et al., 2006).
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B2–Cdc2 activities during mitotic exit for proper Golgi and ER
reassembly to occur, although we cannot exclude the possibility
that Myt1 has other unidentified targets.
Our results also suggest that Myt1-mediated suppression
of cyclin B1– and cyclin B2–Cdc2 activities may not be indispensable for the regulation of a broad range of mitotic events,
such as regulation of mitotic entry timing and spindle assembly,
although we cannot exclude the possibility that the depletion of
Myt1 was insufficient to yield the phenotype. However, it is
certain that the effect of Myt1 depletion was primarily seen in
Golgi and ER reassembly, not in mitotic entry timing. How can
such a difference of the effects of Myt1 depletion arise? It does
not seem to depend on the cyclin-type specificity of Myt1 because Myt1 inhibits not only cyclin B1–Cdc2 activity but also
cyclin A2–Cdc2 activity in vitro (Booher et al., 1997). We speculate that the inhibitory effect of Myt1 toward Cdc2 may not be
strong enough to inhibit the whole population of cyclin–Cdc2
complexes at G2/M phase, in which total A- and B-type cyclins
are abundant. In contrast, because the protein levels of Cdc2–
cyclins are very low in late mitosis, Myt1 may inhibit Cdc2 activity completely, and the effect of Myt1 may become prominent
in this period. Thus, we think that the difference of the effects of
Myt1 on mitotic entry timing and Golgi/ER reassembly may
arise from the limited inhibitory effect of Myt1 toward Cdc2.
In summary, we have revealed that Myt1 is required for the control of intracellular membrane dynamics such as Golgi and ER
reassembly during mitosis in mammalian somatic cell cycles.
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Even during mitosis, the continuity of the luminal side of the
organelle is maintained (Ellenberg et al., 1997; Terasaki, 2000).
However, the precise structural features of the ER network in
mitotic cells are less clear. The round shape of mitotic cells
makes it difficult to observe the precise structures of the ER.
In this study, we show that Myt1 is essential for ER meshwork
formation during mitotic exit but not for its maintenance in
interphase. This result suggests that ER may undergo dynamic
morphological changes during mitosis. Furthermore, our data
show that Myt1 facilitates reassembly of a fine interphase-type
ER meshwork during mitotic exit through inhibition of cyclin
B1 and cyclin B2. This finding suggests that Cdc2 activity may
play a pivotal role in dynamic morphological changes of ER
during mitosis. Previous studies also suggested that Cdc2 might
be involved in the regulation of ER morphology (Dreier and
Rapoport, 2000; Kano et al., 2005). In semi-intact cells, an elaborate meshwork of ER is disrupted by a mitotic cytosol, and
the disruption is dependent on Cdc2 kinase (Kano et al., 2005).
In vitro, de novo formation of ER meshwork from microsomal
vesicles occurs in interphase extracts but not in Cdc2 kinase–
activated interphase extracts (Dreier and Rapoport, 2000). Thus,
Cdc2 activity has the ability to disrupt the elaborate ER meshwork. These results are in agreement with our idea that Myt1mediated inhibition of Cdc2 activity during mitotic exit is
important for the formation of an elaborate ER meshwork.
Cdc2 activities associated with B-type cyclins have been
thought to play an important role in inducing a broad range of
mitotic events, including mitotic Golgi fragmentation. However, our results show that even when both cyclin B1 and cyclin
B2 expression are inhibited, the Golgi fragmentation and reassembly during mitosis occur almost normally, and ER meshwork changes during mitosis also occur almost normally (Fig. 9).
These observations suggest that cyclin B1 and cyclin B2 are
dispensable for Golgi fragmentation and ER reorganization during early mitosis. Most recently, Gong et al. (2007) reported
that the timing of nuclear envelope breakdown was affected
very little by knocking down both cyclin B1 and cyclin B2 but
was markedly delayed by knocking down cyclin A2. Gong et al.
(2007) then also concluded that cyclin A2 is crucial for nuclear
envelope breakdown. Thus, it is likely that cyclin A2, both in
the absence or presence of cyclin B1 and cyclin B2, may play a
pivotal role in Golgi disassembly and ER network reorganization during mitosis, although it is also possible that very low
levels of cyclin B1 and cyclin B2, which remain in cyclin B1/
cyclin B2 double siRNA–treated cells, play a role in these processes in combination with cyclin A2. Cyclin A2, which is thus
implicated in the early mitotic events, is always degraded before
cyclin B1 and cyclin B2 (den Elzen and Pines, 2001). Although
cyclin B1 and cyclin B2 are mostly degraded at metaphase/
anaphase, both cyclin B1 and cyclin B2 proteins appear to be
present at very low levels during late mitosis (Fig. 10 A).
Thus, when Golgi and ER reassembly occur during telophase,
the low levels of B-type cyclins are present as partners of
Cdc2. Because the kinase activity of the remaining cyclin B1–
and cyclin B2–Cdc2 would prevent Golgi and ER reassembly,
their activities must be suppressed during mitotic exit. Our results suggest that Myt1 might inhibit both cyclin B1– and cyclin

Materials and methods
Cell culture and synchronization
HeLa cells were cultured in DME containing 10% FBS or 10% calf serum.
To synchronize cells, HeLa cells were arrested at the G1/S boundary by a
double-thymidine block and were released from the arrest by washing with
fresh medium. 50 μM MG132 (EMD) was added into the medium 8 h after
the release from double-thymidine block and was incubated. For transfection with DNA vectors and siRNAs during synchronization, cells were
transfected with DNA vectors in Opti-MEM with the use of Lipofectamine
Plus (Invitrogen) for 1 h and were washed into fresh medium containing
thymidine for the ﬁrst block. Then, cells were transfected with siRNAs by
the use of Oligofectamine (Invitrogen) after the ﬁrst thymidine block. For
time-lapse imaging, synchronized HeLa cells were transfected with DNA
vectors in Opti-MEM with the use of Lipofectamine Plus for 1 h and were
washed into fresh medium containing thymidine for the second block.
Immunoblotting
Cells were lysed in lysis buffer (50 mM Tris, pH 8.0, 100 mM NaCl, 5 mM
EDTA, 0.5% NP-40, 2 mM DTT, 1 mM PMSF, 1 mM Na3VO4, and 2 μg/ml
aprotinin) and centrifuged at 20,000 g for 15 min. The cell extracts were
subjected to immunoblotting with anti-Myt1 (Liu et al., 1997), anti–cyclin
B1 (Santa Cruz Biotechnology, Inc.), anti–␣-tubulin (Sigma-Aldrich), antiWee1 (Santa Cruz Biotechnology, Inc.), anti–cyclin B2 (Santa Cruz Biotechnology, Inc.), anti-Cdc2 (Santa Cruz Biotechnology, Inc.), anti–c-Myc
(Santa Cruz Biotechnology, Inc.), antiphospho-Ser25-GM130 (provided
by M. Lowe, University of Manchester, Manchester, UK; Lowe et al.,
2000), anti-GM130 (BD Biosciences), or anti-GFP antibody (Living Colors;
BD Biosciences).
Phosphatase treatment
Cells were lysed in phosphatase buffer (50 mM Hepes, pH 7.5, 100 mM
NaCl, 0.1 mM EGTA, 0.5% NP-40, 2 mM DTT, 1 mM PMSF, 2 mM MnCl2,
and 2 μg/ml aprotinin) and centrifuged at 20,000 g for 15 min. The cell
extracts were incubated with 300 U of puriﬁed  protein phosphatase
(New England Biolabs, Inc.) for 45 min at 30°C. The phosphatase reaction
was stopped by the addition of the SDS sample buffer. Samples were analyzed by immunoblotting.
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siRNA and add-back experiment
RNA oligonucleotides (21 nucleotides) homologous to human Myt1, cyclin
B1, and cyclin B2 were designed as follows: Myt1 forward (5⬘-GUGACAUCAACUCAGAGCCTT-3⬘) and Myt1 reverse (5⬘-GGCUCUGAGUUGAUGUCACTT-3⬘); cyclin B1 forward (5⬘-UGAAGAUUCUAAGAGCUUUTT-3⬘)
and cyclin B1 reverse (5⬘-AAAGCUCUUAGAAUCUUCATT-3⬘); and cyclin
B2 forward (5⬘-GAGAAUCUCUGCCAAGCUUTT-3⬘) and cyclin B2 reverse
(5⬘-AAGCUUGGCAGAGAUUCUCTT-3⬘). Cells were transfected with annealed siRNAs by the use of Oligofectamine (Invitrogen). In Figs. 1–8, cells
grown in a six-well dish were transfected with 200 pmol Myt1 or Wee1
siRNA. In these conditions, single siRNA treatment for each target almost
completely depleted the cells of the target (Figs. 1 B and 6 A). However,
it was difﬁcult to ﬁnd the conditions in which the triple siRNA treatment for
Myt1, cyclin B1, and cyclin B2 could almost completely abolish the expression of three proteins. In Fig. 10, cells were transfected with 400 pmol
Myt1 siRNA, 100 pmol cyclin B1 siRNA, and 20 pmol cyclin B2 siRNA
for the triple siRNA treatment. In this condition, cyclin B1 expression was
almost completely inhibited, but low levels of Myt1 and cyclin B2 expression remained (Fig. 10 A). We found that when cells were transfected with
100 pmol of single Myt1 siRNA, the remaining Myt1 protein levels were
the same as the remaining Myt1 levels in Myt1/cyclin B1/cyclin B2 triple
siRNA–treated cells (Fig. 10 A), and this level of Myt1 down-regulation
(ⵑ90% depletion) induced the Golgi and ER morphology defects (Fig. 10,
B and C), which were indistinguishable from those resulting from the almost
complete loss of Myt1. In Fig. 10, cells were transfected with 200 pmol
Myt1 siRNA and 100 pmol cyclin B1 siRNA for the double siRNA treatment
for Myt1 and cyclin B1 and were transfected with 400 pmol Myt1 siRNA
and 20 pmol cyclin B2 siRNA for the double siRNA treatment for Myt1 and
cyclin B2. Also, in Figs. 9 and 10, cells were transfected with 100 pmol cyclin B1 siRNA and 20 pmol cyclin B2 siRNA for the double siRNA treatment
for cyclin B1 and cyclin B2. In all siRNA experiments in this manuscript,
control means the procedure without siRNA. We also conﬁrmed that there
was no change in the Golgi and ER morphology when we used Luciferase
siRNA as control siRNA. Silent mutations in the siRNA-targeting region
of Myt1 were introduced by PCR-based mutagenesis using the following
primers: forward (5⬘-GACATCAACTCTGAACCTCCTCGGGGCTC-3⬘; bold
nucleotides indicate silent mutations) and reverse (5⬘-GAGCCCCGAGGAGGTTCAGAGTTGATGTC-3⬘). For add-back experiments, the cells were
transfected with 0.02 μg pCDNA3 vector harboring the siRNA-resistant
form of Myt1 together with 0.5 μg pECFP vector in Opti-MEM with the use
of Lipofectamine Plus for 1 h before the ﬁrst thymidine block.
Immunoprecipitation
Transient transfection with GFP–cyclin B2 and Myc-Myt1 was performed using
FuGENE6 (Roche) according to the manufacturer’s instructions. For immunoprecipitation experiments, cells were lysed in lysis buffer and homogenized.
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Cell lysates were incubated for 2 h at 4°C with anti–cyclin B1, anti–c-Myc,
or anti–cyclin B2 antibody (Santa Cruz Biotechnology, Inc.), and protein A–
Sepharose beads (GE Healthcare) were added and incubated for 2 h.
The precipitates were then washed three times with lysis buffer. The proteins
were separated by SDS-PAGE and analyzed by immunoblotting.
Electron microscopy
Transmission electron microscopic observations were conducted as described previously (Yonemura et al., 1995). For immunolabeling, HeLa cells
were ﬁxed for 10 min with 4% PFA and permeabilized for 10 min with
0.002% saponin in PBS. Cells were blocked for 1 h with 3% BSA, incubated overnight with anti-GM130 antibody, and washed. After incubation
with 1.4-nm colloidal gold-conjugated secondary antibodies (Nanoprobe),
samples were ﬁxed with 1% glutaraldehyde in 0.1 M phosphate buffer, pH
7.4, for 10 min, and the gold particles were intensiﬁed by use of an HQ silver kit (Nanoprobe). The samples were postﬁxed in 0.1% osmium tetroxide
for 90 min on ice, stained with 0.5% uranyl acetate for 2 h, dehydrated
through graded concentrations of ethanol, and embedded in epoxy resin.
Golgi area
Anti-GM130 antibody staining images were obtained using a DeltaVision
Image Restoration microscope with SoftWoRx software. All images were
taken in the same exposure time. Using Photoshop, the acquired images
were binarized to white and black using the ﬁxed threshold in all samples
in each experiment. The white area represents the Golgi apparatus, and
white pixels were measured as relative Golgi area.
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